Concourse Financial Group Securities, Inc. Ligand Pharmaceuticals Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 72 shares of LGND stock, worth $7,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 72
-0.0%
Holding current value
$7,412
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LGND
# of Institutions
236Shares Held
16.5MCall Options Held
77.9KPut Options Held
25K-
Black Rock Inc. New York, NY2.87MShares$295 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$194 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.03MShares$106 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$104 Million0.04% of portfolio
-
Stephens Investment Management Group LLC697KShares$71.7 Million0.7% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.74B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...